Table 4.
Outcome | Women (n = 3,684) | Men (n = 13,368) | ||
---|---|---|---|---|
Multivariablea OR (95% CI) |
p-value | Multivariableb OR (95% CI) |
p-value | |
30-day mortality | 0.429 (0.155–1.189) | 0.104 | 0.641 (0.352–1.165) | 0.145 |
120-day mortality | 0.356 (0.144–0.882) | 0.026 | 0.787 (0.498–1.246) | 0.307 |
Red blood cell transfusion | 0.212 (0.167–0.270) | <0.001 | 0.394 (0.330–0.471) | <0.001 |
Re-exploration for bleeding | 0.542 (0.194–1.512) | 0.242 | 0.524 (0.347–0.791) | 0.002 |
OR odds ratio, CI confidence interval
a Multivariable model corrected for age, obesity, diabetes mellitus, left ventricular ejection fraction (LVEF) <35% and triple-vessel disease
b Multivariable model corrected for age, hypertension, LVEF <35%, estimated glomerular filtration rate and triple-vessel disease